Position in CGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$360,016
-$189,061 QoQ
Shares Held
168,232
-34.7% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#16
of 82 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. CGEN ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in CGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $360,016 | 168,232 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $549,077 | 257,783 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $416,775 | 272,402 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $400,430 | 272,402 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $484,875 | 272,402 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $397,706 | 272,402 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $684,219 | 447,202 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $809,435 | 447,202 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $776,499 | 462,202 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,109,921 | 430,202 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $406,299 | 205,202 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $190,837 | 205,202 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $233,930 | 205,202 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $143,641 | 205,202 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $147,745 | 205,202 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $135,433 | 205,202 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $379,623 | 205,202 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $419,250 | 130,202 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $866,458 | 201,502 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,202,966 | 201,502 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,668,436 | 201,502 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,623,527 | 189,002 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,395,096 | 115,202 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,872,032 | 115,202 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,152,550 | 343,046 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,356,000 | 600,000 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||